SELECT
Evaluation of cardiovascular outcomes with semaglutide in patients with overweight or obesity and prior MI/stroke
- Stadium
- klaar
- Middel
- semaglutide
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 19 februari 2019
- Last Patient In
- 17 maart 2021
- Last Patient Last Visit
- 21 juni 2023
National Lead
dr. A. van Beek
Contact Kantoor
